Encompass Health Corporation (EHC) 10-Year Financial Performance & Capital Metrics

EHC •

HealthcareHealthcare FacilitiesPost-acute and senior care

AboutEncompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families. As of June 1, 2022, it operated 149 hospitals, 252 home health locations, and 99 hospice locations in 42 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.Show more

Revenue $5.94B +10.5%
EBITDA $1.09B -6.5%
Net Income $566M +24.2%
EPS (Diluted) 5.55 +24.4%
Gross Margin 47.5% +14.3%
EBITDA Margin 18.33% -15.4%
Operating Margin 12.81% -20.4%
Net Margin 9.54% +12.5%
ROE 18.49% +4.4%
ROIC 12.74% +4.2%
Debt/Equity 0.08 -91.5%
Interest Coverage 6.17 -1.9%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓Strong Piotroski F-Score: 7/9
✓Strong 5Y sales CAGR of 10.7%
✓Good 3Y average ROE of 17.7%

✗Weaknesses

✗Negative free cash flow

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y6.66%

5Y10.72%

3Y10.92%

TTM11.13%

Profit (Net Income) CAGR

10Y11.95%

5Y14.78%

3Y27.84%

TTM28.08%

EPS CAGR

10Y11.26%

5Y14.26%

3Y27.15%

TTM27.78%

ROCE

10Y Avg15.93%

5Y Avg16.7%

3Y Avg20.36%

Latest12.72%

Peer Comparison

Post-acute and senior care

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
PNTGThe Pennant Group, Inc.	1.18B	33.71	40.13	36.31%	3.12%	7.9%	4.11%	1.21
ENSGThe Ensign Group, Inc.	12.4B	214.17	36.67	18.72%	6.8%	15.46%	2.99%	0.93
NHCNational HealthCare Corporation	2.54B	163.50	21.32	13.23%	6.75%	9.57%	5.86%	0.08
EHCEncompass Health Corporation	10.79B	107.88	19.44	10.46%	9.33%	16.98%		0.08
SEMSelect Medical Holdings Corporation	1.85B	14.97	12.91	5.12%	2.8%	5.47%	20.65%	0.51
BKDBrookdale Senior Living Inc.	3.64B	15.30	-13.66	7.29%	-8.21%	-308.45%	5.99%
SNDASonida Senior Living, Inc.	681.62M	35.89	-66.46	19.19%	-12.39%	-53.82%		5.03

Profit & Loss

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Sales/Revenue+	3.64B	3.91B	4.28B	4.61B	3.57B	4.01B	4.35B	4.8B	5.37B	5.94B
Revenue Growth %	16.91%	7.45%	9.28%	7.66%	-22.56%	12.58%	8.31%	10.41%	11.91%	10.46%
Cost of Goods Sold+	140M	149.3M	158.7M	167.9M	171M	2.31B	2.6B	2.82B	3.14B	3.12B
COGS % of Revenue	3.84%	3.81%	3.71%	3.65%	4.79%	57.57%	59.68%	58.7%	58.44%	52.5%
Gross Profit+	3.5B	3.76B	4.12B	4.44B	3.4B	1.7B	1.75B	1.98B	2.23B	2.82B
Gross Margin %	96.16%	96.19%	96.29%	96.35%	95.21%	42.43%	40.32%	41.3%	41.56%	47.5%
Gross Profit Growth %	17.26%	7.48%	9.4%	7.73%	-23.48%	-49.83%	2.92%	13.1%	12.63%	26.24%
Operating Expenses+	3.5B	3.76B	4.12B	4.44B	3.4B	1.04B	1.12B	258M	1.37B	1.77B
OpEx % of Revenue	96.16%	96.19%	96.29%	96.35%	95.21%	26%	25.82%	5.37%	25.47%	29.76%
Selling, General & Admin	2.19B	2.4B	2.65B	2.9B	2.12B	228.5M	209M	258M	266.5M	236.2M
SG&A % of Revenue	60.14%	61.31%	62.01%	63.02%	59.36%	5.69%	4.81%	5.37%	4.96%	3.98%
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	1.31B	1.36B	1.47B	1.53B	1.28B	815.5M	914M	0	1.1B	1.53B
Operating Income+	648.8M	649.4M	681.6M	692.5M	0	659.4M	630.2M	1.72B	864.5M	760.1M
Operating Margin %	17.81%	16.59%	15.94%	15.04%	-	16.42%	14.49%	35.92%	16.09%	12.81%
Operating Income Growth %	17.07%	0.09%	4.96%	1.6%	-100%	-	-4.43%	173.69%	-49.88%	-12.08%
EBITDA+	821.4M	833.2M	881.3M	911.2M	739.6M	879M	873.8M	2B	1.16B	1.09B
EBITDA Margin %	22.55%	21.29%	20.6%	19.79%	20.74%	21.89%	20.09%	41.63%	21.66%	18.33%
EBITDA Growth %	18.37%	1.44%	5.77%	3.39%	-18.83%	18.85%	-0.59%	128.74%	-41.76%	-6.54%
D&A (Non-Cash Add-back)	172.6M	183.8M	199.7M	218.7M	203M	219.6M	243.6M	273.9M	299.6M	327.9M
EBIT	654.1M	650.8M	640.5M	722M	536.6M	669.3M	626.5M	731.8M	887M	0
Net Interest Income+	-172.1M	-154.4M	-147.3M	-159.7M	-183.7M	-164.3M	-175.7M	-143.5M	-137.4M	0
Interest Income	0	0	0	0	0	0	0	0	0	0
Interest Expense	172.1M	154.4M	147.3M	159.7M	183.7M	164.3M	175.7M	143.5M	137.4M	123.2M
Other Income/Expense	-166.8M	-153M	-188.4M	-130.2M	352.9M	-154.4M	-179.4M	-1.12B	-114.9M	192.9M
Pretax Income+	482M	496.4M	493.2M	562.3M	352.9M	505M	450.8M	607.2M	749.6M	953M
Pretax Margin %	13.23%	12.68%	11.53%	12.21%	9.9%	12.58%	10.37%	12.65%	13.95%	16.06%
Income Tax+	163.9M	145.8M	118.9M	115.9M	74.7M	101.9M	100.1M	132.2M	150.2M	192.9M
Effective Tax Rate %	51.37%	54.61%	59.27%	63.79%	80.53%	81.62%	60.12%	57.97%	60.79%	59.41%
Net Income+	247.6M	271.1M	292.3M	358.7M	284.2M	412.2M	271M	352M	455.7M	566.2M
Net Margin %	6.8%	6.93%	6.83%	7.79%	7.97%	10.27%	6.23%	7.33%	8.48%	9.54%
Net Income Growth %	35.23%	9.49%	7.82%	22.72%	-20.77%	45.04%	-34.26%	29.89%	29.46%	24.25%
Net Income (Continuing)	318.1M	350.6M	374.3M	446.4M	278.2M	403.1M	350.7M	475M	599.4M	760.1M
Discontinued Operations	0	-400K	1.1M	-600K	90.6M	114.1M	15.2M	-12M	-2.8M	0
Minority Interest	331.1M	463.8M	542M	580.5M	413.6M	487.9M	551.6M	649.7M	782.2M	58.3M
EPS (Diluted)+	2.59	2.69	2.93	3.61	2.85	4.11	2.70	3.47	4.46	5.55
EPS Growth %	35.6%	3.86%	8.92%	23.21%	-21.05%	44.21%	-34.31%	28.52%	28.53%	24.44%
EPS (Basic)	2.77	2.73	2.99	3.65	2.87	4.15	2.72	3.54	4.53	5.63
Diluted Shares Outstanding	99.5M	99.3M	99.8M	99.4M	99.8M	100.2M	100.4M	101.3M	102.2M	102.2M
Basic Shares Outstanding	89.1M	93.7M	97.9M	98M	98.6M	99M	99.2M	99.5M	99.9M	100.5M
Dividend Payout Ratio	33.84%	33.75%	34.49%	30.3%	39.37%	27.22%	36.53%	17.16%	13.78%	-

Balance Sheet

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Current Assets+	654.5M	702.2M	662.1M	755.8M	948.6M	921.4M	717.2M	841.8M	886.9M	905.9M
Cash & Short-Term Investments	40.5M	54.4M	69.2M	94.8M	224M	49.4M	21.8M	141.8M	85.4M	72.2M
Cash Only	40.5M	54.4M	69.2M	94.8M	224M	49.4M	21.8M	104.2M	85.4M	72.2M
Short-Term Investments	0	0	0	0	0	0	0	37.6M	0	0
Accounts Receivable	443.8M	472.1M	467.7M	498.7M	563M	502.1M	536.8M	611.6M	598.8M	619.2M
Days Sales Outstanding	44.47	44.03	39.91	39.53	57.62	45.65	45.06	46.5	40.68	38.08
Inventory	60.9M	62.4M	59M	0	0	0	0	0	0	0
Days Inventory Outstanding	158.78	152.55	135.7	-	-	-	-	-	-	-
Other Current Assets	60.9M	62.4M	59M	64.8M	75.2M	255M	123.7M	53.9M	160.4M	214.5M
Total Non-Current Assets+	4.03B	4.19B	4.57B	5.32B	5.5B	5.94B	4.92B	5.26B	5.65B	6.18B
Property, Plant & Equipment	1.39B	1.52B	1.63B	2.24B	2.45B	2.77B	3.15B	3.51B	3.85B	4.31B
Fixed Asset Turnover	2.62x	2.58x	2.62x	2.06x	1.45x	1.45x	1.38x	1.37x	1.40x	1.38x
Goodwill	1.93B	1.97B	2.1B	2.31B	2.32B	1.24B	1.26B	1.28B	1.28B	1.32B
Intangible Assets	411.3M	403.1M	443.4M	476.3M	431.3M	158.4M	282.3M	278.2M	297.8M	308.3M
Long-Term Investments	46.5M	56.1M	74.2M	7.4M	5.5M	0	0	109.5M	122.5M	0
Other Non-Current Assets	174.8M	179M	216.8M	300.2M	289.5M	1.77B	222.1M	82.1M	96.7M	243.7M
Total Assets+	4.68B	4.89B	5.23B	6.08B	6.45B	6.86B	5.64B	6.1B	6.53B	7.09B
Asset Turnover	0.78x	0.80x	0.82x	0.76x	0.55x	0.58x	0.77x	0.79x	0.82x	0.84x
Asset Growth %	1.65%	4.52%	6.82%	16.32%	6.01%	6.5%	-17.89%	8.27%	7.08%	8.49%
Total Current Liabilities+	475.6M	517.5M	672.5M	721M	717.3M	748.8M	575.9M	656.4M	841M	836.4M
Accounts Payable	68.3M	78.4M	90M	94.6M	115M	134M	132.9M	170M	171M	178.2M
Days Payables Outstanding	178.07	191.67	206.99	205.65	245.47	21.16	18.69	22.02	19.88	20.87
Short-Term Debt	37.1M	32.3M	35.8M	18.3M	14.5M	18.7M	25.2M	48.9M	114.9M	70.1M
Deferred Revenue (Current)	173.1M	196.8M	212.8M	0	0	0	0	0	0	0
Other Current Liabilities	136.1M	149.1M	292.6M	162.7M	174.3M	264.1M	181.1M	230M	505.1M	588.1M
Current Ratio	1.38x	1.36x	0.98x	1.05x	1.32x	1.23x	1.25x	1.28x	1.05x	1.08x
Quick Ratio	1.25x	1.24x	0.90x	1.05x	1.32x	1.23x	1.25x	1.28x	1.05x	1.08x
Cash Conversion Cycle	25.18	4.91	-31.39	-	-	-	-	-	-	-
Total Non-Current Liabilities+	3.14B	2.73B	2.68B	3.43B	3.73B	3.72B	3.2B	3.15B	2.84B	2.98B
Long-Term Debt	2.98B	2.55B	2.48B	2.63B	2.85B	2.85B	2.74B	2.37B	2.06B	196.6M
Capital Lease Obligations	0	0	0	634.9M	605.5M	568.8M	199.7M	514.6M	484.4M	0
Deferred Tax Liabilities	0	0	0	0	0	0	83M	87M	105.2M	126.8M
Other Non-Current Liabilities	160M	185.3M	205.2M	159.9M	266.8M	296.8M	174.2M	177.9M	190.4M	2.65B
Total Liabilities	3.61B	3.25B	3.36B	4.15B	4.44B	4.47B	3.77B	3.81B	3.69B	3.81B
Total Debt+	3.02B	2.58B	2.51B	3.35B	3.54B	3.48B	2.99B	2.93B	2.71B	266.7M
Net Debt	2.98B	2.52B	2.45B	3.25B	3.32B	3.43B	2.97B	2.83B	2.63B	194.5M
Debt / Equity	2.83x	1.57x	1.34x	1.73x	1.77x	1.45x	1.61x	1.28x	0.95x	0.08x
Debt / EBITDA	3.67x	3.09x	2.85x	3.67x	4.79x	3.96x	3.42x	1.47x	2.33x	0.25x
Net Debt / EBITDA	3.62x	3.03x	2.77x	3.57x	4.49x	3.90x	3.40x	1.42x	2.26x	0.18x
Interest Coverage	3.77x	4.21x	4.63x	4.34x	-	4.01x	3.59x	12.02x	6.29x	6.17x
Total Equity+	1.07B	1.65B	1.87B	1.93B	2B	2.4B	1.86B	2.3B	2.85B	3.28B
Equity Growth %	18.5%	54.22%	13.71%	3.29%	3.56%	19.86%	-22.39%	23.38%	24.03%	14.97%
Book Value per Share	10.72	16.57	18.75	19.44	20.06	23.94	18.54	22.68	27.88	32.05
Total Shareholders' Equity	735.9M	1.18B	1.33B	1.35B	1.59B	1.91B	1.31B	1.65B	2.07B	3.22B
Common Stock	1.1M	1.1M	1.1M	1.1M	1.1M	1.1M	1.1M	1.2M	1.2M	0
Retained Earnings	-1.45B	-1.19B	-885.2M	-526.5M	-242.3M	141.8M	115.7M	406.5M	796.7M	0
Treasury Stock	-614.7M	-418.5M	-427.9M	-492.3M	-497.4M	-521.2M	-536.7M	-547.2M	-577.9M	0
Accumulated OCI	-1.2M	-1.3M	0	0	0	0	0	0	0	0
Minority Interest	331.1M	463.8M	542M	580.5M	413.6M	487.9M	551.6M	649.7M	782.2M	58.3M

Cash Flow

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Cash from Operations+	605.5M	657.2M	762.4M	635.3M	704.7M	715.8M	705.8M	850.8M	1B	-1.4M
Operating CF Margin %	16.62%	16.79%	17.82%	13.8%	19.76%	17.83%	16.23%	17.72%	18.66%	-0.02%
Operating CF Growth %	24.9%	8.54%	16.01%	-16.67%	10.92%	1.58%	-1.4%	20.54%	17.87%	-100.14%
Net Income	318.1M	335.8M	374.3M	446.4M	284.2M	517.6M	365.9M	361.6M	599.4M	759.1M
Depreciation & Amortization	172.6M	183.8M	199.7M	218.7M	243M	219.6M	243.6M	273.9M	299.6M	327.9M
Stock-Based Compensation	27.4M	47.7M	85.9M	114.4M	25.6M	29.1M	29.2M	50.6M	48.3M	56.5M
Deferred Taxes	132.9M	75.6M	-9.1M	40M	52.4M	17.4M	27.9M	3.9M	10.7M	22.3M
Other Non-Cash Items	63.2M	75.2M	65.6M	-4.1M	5.6M	50.1M	69.6M	110.5M	22.9M	-1.17B
Working Capital Changes	-108.7M	-60.9M	46M	-180.1M	93.9M	-118M	-30.4M	50.3M	21.9M	0
Change in Receivables	-127.5M	-83.9M	7M	-22.9M	-5.1M	-64.3M	-16.9M	-22.4M	3M	-15.2M
Change in Inventory	18.3M	25.9M	-2.4M	0	0	0	0	0	0	0
Change in Payables	6.3M	7.5M	6.6M	-6.1M	0	14.9M	2.3M	11.8M	3M	-22.6M
Cash from Investing+	-245M	-284.5M	-424.5M	-657.4M	-407.5M	-666.3M	-627M	-602.8M	-653.3M	-764.6M
Capital Expenditures	-202.9M	-245M	-270.5M	-404.1M	-408.2M	-551.2M	-584.1M	-583.1M	-642.5M	-736.4M
CapEx % of Revenue	5.57%	6.26%	6.32%	8.78%	11.45%	13.73%	13.43%	12.14%	11.96%	12.41%
Acquisitions	-48.1M	-38.8M	-143.9M	-231.5M	-1.1M	-118.6M	64.1M	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	31.1M	18.5M	-8.4M	-6.5M	-2.1M	3.5M	-7.7M	3.3M	-7.2M	-16.6M
Cash from Financing+	-381.6M	-359.9M	-321.2M	48.2M	-145.9M	-240.1M	-145.7M	-197.2M	-330.6M	-431.2M
Debt Issued (Net)	-193.4M	-202.2M	-103.5M	476M	215.9M	-59.1M	-498.2M	-83.3M	-242M	0
Equity Issued (Net)	-1000K	-1000K	0	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	0
Dividends Paid	-83.8M	-91.5M	-100.8M	-108.7M	-111.9M	-112.2M	-99M	-60.4M	-62.8M	-71.1M
Share Repurchases	-65.6M	-38.1M	-65.6M	-45.9M	-6.1M	-14.6M	-7.3M	-8.2M	-31.1M	-158M
Other Financing	-67.7M	-8.3M	-116.9M	-273.2M	-243.8M	-54.2M	458.8M	-45.3M	5.3M	-360.1M
Net Change in Cash	-21.1M	13.9M	16.7M	26.1M	151.3M	-190.6M	-66.9M	50.8M	18.9M	-20.2M
Free Cash Flow+	402.6M	412.2M	491.9M	231.2M	296.5M	164.6M	121.7M	267.7M	360.3M	-737.8M
FCF Margin %	11.05%	10.53%	11.5%	5.02%	8.31%	4.1%	2.8%	5.58%	6.71%	-12.43%
FCF Growth %	22.63%	2.38%	19.34%	-53%	28.24%	-44.49%	-26.06%	119.97%	34.59%	-304.77%
FCF per Share	4.05	4.15	4.93	2.33	2.97	1.64	1.21	2.64	3.53	-7.22
FCF Conversion (FCF/Net Income)	2.45x	2.42x	2.61x	1.77x	2.48x	1.74x	2.60x	2.42x	2.20x	-0.00x
Interest Paid	164.3M	150.5M	149.6M	155.7M	168.4M	168.4M	178.4M	147.7M	146.8M	0
Taxes Paid	33.3M	96.4M	115.4M	104.2M	34.3M	131.4M	51.2M	109.3M	164.5M	0

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	25.17%	19.99%	16.62%	18.86%	14.45%	18.73%	12.72%	16.93%	17.71%	18.49%
Return on Invested Capital (ROIC)	12.08%	11.86%	12.05%	10.93%	-	8.87%	8.86%	25.98%	12.23%	12.74%
Gross Margin	96.16%	96.19%	96.29%	96.35%	95.21%	42.43%	40.32%	41.3%	41.56%	47.5%
Net Margin	6.8%	6.93%	6.83%	7.79%	7.97%	10.27%	6.23%	7.33%	8.48%	9.54%
Debt / Equity	2.83x	1.57x	1.34x	1.73x	1.77x	1.45x	1.61x	1.28x	0.95x	0.08x
Interest Coverage	3.77x	4.21x	4.63x	4.34x	-	4.01x	3.59x	12.02x	6.29x	6.17x
FCF Conversion	2.45x	2.42x	2.61x	1.77x	2.48x	1.74x	2.60x	2.42x	2.20x	-0.00x
Revenue Growth	16.91%	7.45%	9.28%	7.66%	-22.56%	12.58%	8.31%	10.41%	11.91%	10.46%

US Stock Screener

...

Encompass Health Corporation (EHC) 10-Year Financial Performance & Capital Metrics

EHC •

HealthcareHealthcare FacilitiesPost-acute and senior care

Revenue $5.94B +10.5%
EBITDA $1.09B -6.5%
Net Income $566M +24.2%
EPS (Diluted) 5.55 +24.4%
Gross Margin 47.5% +14.3%
EBITDA Margin 18.33% -15.4%
Operating Margin 12.81% -20.4%
Net Margin 9.54% +12.5%
ROE 18.49% +4.4%
ROIC 12.74% +4.2%
Debt/Equity 0.08 -91.5%
Interest Coverage 6.17 -1.9%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓Strong Piotroski F-Score: 7/9
✓Strong 5Y sales CAGR of 10.7%
✓Good 3Y average ROE of 17.7%

✗Weaknesses

✗Negative free cash flow

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y6.66%

5Y10.72%

3Y10.92%

TTM11.13%

Profit (Net Income) CAGR

10Y11.95%

5Y14.78%

3Y27.84%

TTM28.08%

EPS CAGR

10Y11.26%

5Y14.26%

3Y27.15%

TTM27.78%

ROCE

10Y Avg15.93%

5Y Avg16.7%

3Y Avg20.36%

Latest12.72%

Peer Comparison

Post-acute and senior care

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
PNTGThe Pennant Group, Inc.	1.18B	33.71	40.13	36.31%	3.12%	7.9%	4.11%	1.21
ENSGThe Ensign Group, Inc.	12.4B	214.17	36.67	18.72%	6.8%	15.46%	2.99%	0.93
NHCNational HealthCare Corporation	2.54B	163.50	21.32	13.23%	6.75%	9.57%	5.86%	0.08
EHCEncompass Health Corporation	10.79B	107.88	19.44	10.46%	9.33%	16.98%		0.08
SEMSelect Medical Holdings Corporation	1.85B	14.97	12.91	5.12%	2.8%	5.47%	20.65%	0.51
BKDBrookdale Senior Living Inc.	3.64B	15.30	-13.66	7.29%	-8.21%	-308.45%	5.99%
SNDASonida Senior Living, Inc.	681.62M	35.89	-66.46	19.19%	-12.39%	-53.82%		5.03

Profit & Loss

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Sales/Revenue+	3.64B	3.91B	4.28B	4.61B	3.57B	4.01B	4.35B	4.8B	5.37B	5.94B
Revenue Growth %	16.91%	7.45%	9.28%	7.66%	-22.56%	12.58%	8.31%	10.41%	11.91%	10.46%
Cost of Goods Sold+	140M	149.3M	158.7M	167.9M	171M	2.31B	2.6B	2.82B	3.14B	3.12B
COGS % of Revenue	3.84%	3.81%	3.71%	3.65%	4.79%	57.57%	59.68%	58.7%	58.44%	52.5%
Gross Profit+	3.5B	3.76B	4.12B	4.44B	3.4B	1.7B	1.75B	1.98B	2.23B	2.82B
Gross Margin %	96.16%	96.19%	96.29%	96.35%	95.21%	42.43%	40.32%	41.3%	41.56%	47.5%
Gross Profit Growth %	17.26%	7.48%	9.4%	7.73%	-23.48%	-49.83%	2.92%	13.1%	12.63%	26.24%
Operating Expenses+	3.5B	3.76B	4.12B	4.44B	3.4B	1.04B	1.12B	258M	1.37B	1.77B
OpEx % of Revenue	96.16%	96.19%	96.29%	96.35%	95.21%	26%	25.82%	5.37%	25.47%	29.76%
Selling, General & Admin	2.19B	2.4B	2.65B	2.9B	2.12B	228.5M	209M	258M	266.5M	236.2M
SG&A % of Revenue	60.14%	61.31%	62.01%	63.02%	59.36%	5.69%	4.81%	5.37%	4.96%	3.98%
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	1.31B	1.36B	1.47B	1.53B	1.28B	815.5M	914M	0	1.1B	1.53B
Operating Income+	648.8M	649.4M	681.6M	692.5M	0	659.4M	630.2M	1.72B	864.5M	760.1M
Operating Margin %	17.81%	16.59%	15.94%	15.04%	-	16.42%	14.49%	35.92%	16.09%	12.81%
Operating Income Growth %	17.07%	0.09%	4.96%	1.6%	-100%	-	-4.43%	173.69%	-49.88%	-12.08%
EBITDA+	821.4M	833.2M	881.3M	911.2M	739.6M	879M	873.8M	2B	1.16B	1.09B
EBITDA Margin %	22.55%	21.29%	20.6%	19.79%	20.74%	21.89%	20.09%	41.63%	21.66%	18.33%
EBITDA Growth %	18.37%	1.44%	5.77%	3.39%	-18.83%	18.85%	-0.59%	128.74%	-41.76%	-6.54%
D&A (Non-Cash Add-back)	172.6M	183.8M	199.7M	218.7M	203M	219.6M	243.6M	273.9M	299.6M	327.9M
EBIT	654.1M	650.8M	640.5M	722M	536.6M	669.3M	626.5M	731.8M	887M	0
Net Interest Income+	-172.1M	-154.4M	-147.3M	-159.7M	-183.7M	-164.3M	-175.7M	-143.5M	-137.4M	0
Interest Income	0	0	0	0	0	0	0	0	0	0
Interest Expense	172.1M	154.4M	147.3M	159.7M	183.7M	164.3M	175.7M	143.5M	137.4M	123.2M
Other Income/Expense	-166.8M	-153M	-188.4M	-130.2M	352.9M	-154.4M	-179.4M	-1.12B	-114.9M	192.9M
Pretax Income+	482M	496.4M	493.2M	562.3M	352.9M	505M	450.8M	607.2M	749.6M	953M
Pretax Margin %	13.23%	12.68%	11.53%	12.21%	9.9%	12.58%	10.37%	12.65%	13.95%	16.06%
Income Tax+	163.9M	145.8M	118.9M	115.9M	74.7M	101.9M	100.1M	132.2M	150.2M	192.9M
Effective Tax Rate %	51.37%	54.61%	59.27%	63.79%	80.53%	81.62%	60.12%	57.97%	60.79%	59.41%
Net Income+	247.6M	271.1M	292.3M	358.7M	284.2M	412.2M	271M	352M	455.7M	566.2M
Net Margin %	6.8%	6.93%	6.83%	7.79%	7.97%	10.27%	6.23%	7.33%	8.48%	9.54%
Net Income Growth %	35.23%	9.49%	7.82%	22.72%	-20.77%	45.04%	-34.26%	29.89%	29.46%	24.25%
Net Income (Continuing)	318.1M	350.6M	374.3M	446.4M	278.2M	403.1M	350.7M	475M	599.4M	760.1M
Discontinued Operations	0	-400K	1.1M	-600K	90.6M	114.1M	15.2M	-12M	-2.8M	0
Minority Interest	331.1M	463.8M	542M	580.5M	413.6M	487.9M	551.6M	649.7M	782.2M	58.3M
EPS (Diluted)+	2.59	2.69	2.93	3.61	2.85	4.11	2.70	3.47	4.46	5.55
EPS Growth %	35.6%	3.86%	8.92%	23.21%	-21.05%	44.21%	-34.31%	28.52%	28.53%	24.44%
EPS (Basic)	2.77	2.73	2.99	3.65	2.87	4.15	2.72	3.54	4.53	5.63
Diluted Shares Outstanding	99.5M	99.3M	99.8M	99.4M	99.8M	100.2M	100.4M	101.3M	102.2M	102.2M
Basic Shares Outstanding	89.1M	93.7M	97.9M	98M	98.6M	99M	99.2M	99.5M	99.9M	100.5M
Dividend Payout Ratio	33.84%	33.75%	34.49%	30.3%	39.37%	27.22%	36.53%	17.16%	13.78%	-

Balance Sheet

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Current Assets+	654.5M	702.2M	662.1M	755.8M	948.6M	921.4M	717.2M	841.8M	886.9M	905.9M
Cash & Short-Term Investments	40.5M	54.4M	69.2M	94.8M	224M	49.4M	21.8M	141.8M	85.4M	72.2M
Cash Only	40.5M	54.4M	69.2M	94.8M	224M	49.4M	21.8M	104.2M	85.4M	72.2M
Short-Term Investments	0	0	0	0	0	0	0	37.6M	0	0
Accounts Receivable	443.8M	472.1M	467.7M	498.7M	563M	502.1M	536.8M	611.6M	598.8M	619.2M
Days Sales Outstanding	44.47	44.03	39.91	39.53	57.62	45.65	45.06	46.5	40.68	38.08
Inventory	60.9M	62.4M	59M	0	0	0	0	0	0	0
Days Inventory Outstanding	158.78	152.55	135.7	-	-	-	-	-	-	-
Other Current Assets	60.9M	62.4M	59M	64.8M	75.2M	255M	123.7M	53.9M	160.4M	214.5M
Total Non-Current Assets+	4.03B	4.19B	4.57B	5.32B	5.5B	5.94B	4.92B	5.26B	5.65B	6.18B
Property, Plant & Equipment	1.39B	1.52B	1.63B	2.24B	2.45B	2.77B	3.15B	3.51B	3.85B	4.31B
Fixed Asset Turnover	2.62x	2.58x	2.62x	2.06x	1.45x	1.45x	1.38x	1.37x	1.40x	1.38x
Goodwill	1.93B	1.97B	2.1B	2.31B	2.32B	1.24B	1.26B	1.28B	1.28B	1.32B
Intangible Assets	411.3M	403.1M	443.4M	476.3M	431.3M	158.4M	282.3M	278.2M	297.8M	308.3M
Long-Term Investments	46.5M	56.1M	74.2M	7.4M	5.5M	0	0	109.5M	122.5M	0
Other Non-Current Assets	174.8M	179M	216.8M	300.2M	289.5M	1.77B	222.1M	82.1M	96.7M	243.7M
Total Assets+	4.68B	4.89B	5.23B	6.08B	6.45B	6.86B	5.64B	6.1B	6.53B	7.09B
Asset Turnover	0.78x	0.80x	0.82x	0.76x	0.55x	0.58x	0.77x	0.79x	0.82x	0.84x
Asset Growth %	1.65%	4.52%	6.82%	16.32%	6.01%	6.5%	-17.89%	8.27%	7.08%	8.49%
Total Current Liabilities+	475.6M	517.5M	672.5M	721M	717.3M	748.8M	575.9M	656.4M	841M	836.4M
Accounts Payable	68.3M	78.4M	90M	94.6M	115M	134M	132.9M	170M	171M	178.2M
Days Payables Outstanding	178.07	191.67	206.99	205.65	245.47	21.16	18.69	22.02	19.88	20.87
Short-Term Debt	37.1M	32.3M	35.8M	18.3M	14.5M	18.7M	25.2M	48.9M	114.9M	70.1M
Deferred Revenue (Current)	173.1M	196.8M	212.8M	0	0	0	0	0	0	0
Other Current Liabilities	136.1M	149.1M	292.6M	162.7M	174.3M	264.1M	181.1M	230M	505.1M	588.1M
Current Ratio	1.38x	1.36x	0.98x	1.05x	1.32x	1.23x	1.25x	1.28x	1.05x	1.08x
Quick Ratio	1.25x	1.24x	0.90x	1.05x	1.32x	1.23x	1.25x	1.28x	1.05x	1.08x
Cash Conversion Cycle	25.18	4.91	-31.39	-	-	-	-	-	-	-
Total Non-Current Liabilities+	3.14B	2.73B	2.68B	3.43B	3.73B	3.72B	3.2B	3.15B	2.84B	2.98B
Long-Term Debt	2.98B	2.55B	2.48B	2.63B	2.85B	2.85B	2.74B	2.37B	2.06B	196.6M
Capital Lease Obligations	0	0	0	634.9M	605.5M	568.8M	199.7M	514.6M	484.4M	0
Deferred Tax Liabilities	0	0	0	0	0	0	83M	87M	105.2M	126.8M
Other Non-Current Liabilities	160M	185.3M	205.2M	159.9M	266.8M	296.8M	174.2M	177.9M	190.4M	2.65B
Total Liabilities	3.61B	3.25B	3.36B	4.15B	4.44B	4.47B	3.77B	3.81B	3.69B	3.81B
Total Debt+	3.02B	2.58B	2.51B	3.35B	3.54B	3.48B	2.99B	2.93B	2.71B	266.7M
Net Debt	2.98B	2.52B	2.45B	3.25B	3.32B	3.43B	2.97B	2.83B	2.63B	194.5M
Debt / Equity	2.83x	1.57x	1.34x	1.73x	1.77x	1.45x	1.61x	1.28x	0.95x	0.08x
Debt / EBITDA	3.67x	3.09x	2.85x	3.67x	4.79x	3.96x	3.42x	1.47x	2.33x	0.25x
Net Debt / EBITDA	3.62x	3.03x	2.77x	3.57x	4.49x	3.90x	3.40x	1.42x	2.26x	0.18x
Interest Coverage	3.77x	4.21x	4.63x	4.34x	-	4.01x	3.59x	12.02x	6.29x	6.17x
Total Equity+	1.07B	1.65B	1.87B	1.93B	2B	2.4B	1.86B	2.3B	2.85B	3.28B
Equity Growth %	18.5%	54.22%	13.71%	3.29%	3.56%	19.86%	-22.39%	23.38%	24.03%	14.97%
Book Value per Share	10.72	16.57	18.75	19.44	20.06	23.94	18.54	22.68	27.88	32.05
Total Shareholders' Equity	735.9M	1.18B	1.33B	1.35B	1.59B	1.91B	1.31B	1.65B	2.07B	3.22B
Common Stock	1.1M	1.1M	1.1M	1.1M	1.1M	1.1M	1.1M	1.2M	1.2M	0
Retained Earnings	-1.45B	-1.19B	-885.2M	-526.5M	-242.3M	141.8M	115.7M	406.5M	796.7M	0
Treasury Stock	-614.7M	-418.5M	-427.9M	-492.3M	-497.4M	-521.2M	-536.7M	-547.2M	-577.9M	0
Accumulated OCI	-1.2M	-1.3M	0	0	0	0	0	0	0	0
Minority Interest	331.1M	463.8M	542M	580.5M	413.6M	487.9M	551.6M	649.7M	782.2M	58.3M

Cash Flow

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Cash from Operations+	605.5M	657.2M	762.4M	635.3M	704.7M	715.8M	705.8M	850.8M	1B	-1.4M
Operating CF Margin %	16.62%	16.79%	17.82%	13.8%	19.76%	17.83%	16.23%	17.72%	18.66%	-0.02%
Operating CF Growth %	24.9%	8.54%	16.01%	-16.67%	10.92%	1.58%	-1.4%	20.54%	17.87%	-100.14%
Net Income	318.1M	335.8M	374.3M	446.4M	284.2M	517.6M	365.9M	361.6M	599.4M	759.1M
Depreciation & Amortization	172.6M	183.8M	199.7M	218.7M	243M	219.6M	243.6M	273.9M	299.6M	327.9M
Stock-Based Compensation	27.4M	47.7M	85.9M	114.4M	25.6M	29.1M	29.2M	50.6M	48.3M	56.5M
Deferred Taxes	132.9M	75.6M	-9.1M	40M	52.4M	17.4M	27.9M	3.9M	10.7M	22.3M
Other Non-Cash Items	63.2M	75.2M	65.6M	-4.1M	5.6M	50.1M	69.6M	110.5M	22.9M	-1.17B
Working Capital Changes	-108.7M	-60.9M	46M	-180.1M	93.9M	-118M	-30.4M	50.3M	21.9M	0
Change in Receivables	-127.5M	-83.9M	7M	-22.9M	-5.1M	-64.3M	-16.9M	-22.4M	3M	-15.2M
Change in Inventory	18.3M	25.9M	-2.4M	0	0	0	0	0	0	0
Change in Payables	6.3M	7.5M	6.6M	-6.1M	0	14.9M	2.3M	11.8M	3M	-22.6M
Cash from Investing+	-245M	-284.5M	-424.5M	-657.4M	-407.5M	-666.3M	-627M	-602.8M	-653.3M	-764.6M
Capital Expenditures	-202.9M	-245M	-270.5M	-404.1M	-408.2M	-551.2M	-584.1M	-583.1M	-642.5M	-736.4M
CapEx % of Revenue	5.57%	6.26%	6.32%	8.78%	11.45%	13.73%	13.43%	12.14%	11.96%	12.41%
Acquisitions	-48.1M	-38.8M	-143.9M	-231.5M	-1.1M	-118.6M	64.1M	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	31.1M	18.5M	-8.4M	-6.5M	-2.1M	3.5M	-7.7M	3.3M	-7.2M	-16.6M
Cash from Financing+	-381.6M	-359.9M	-321.2M	48.2M	-145.9M	-240.1M	-145.7M	-197.2M	-330.6M	-431.2M
Debt Issued (Net)	-193.4M	-202.2M	-103.5M	476M	215.9M	-59.1M	-498.2M	-83.3M	-242M	0
Equity Issued (Net)	-1000K	-1000K	0	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	0
Dividends Paid	-83.8M	-91.5M	-100.8M	-108.7M	-111.9M	-112.2M	-99M	-60.4M	-62.8M	-71.1M
Share Repurchases	-65.6M	-38.1M	-65.6M	-45.9M	-6.1M	-14.6M	-7.3M	-8.2M	-31.1M	-158M
Other Financing	-67.7M	-8.3M	-116.9M	-273.2M	-243.8M	-54.2M	458.8M	-45.3M	5.3M	-360.1M
Net Change in Cash	-21.1M	13.9M	16.7M	26.1M	151.3M	-190.6M	-66.9M	50.8M	18.9M	-20.2M
Free Cash Flow+	402.6M	412.2M	491.9M	231.2M	296.5M	164.6M	121.7M	267.7M	360.3M	-737.8M
FCF Margin %	11.05%	10.53%	11.5%	5.02%	8.31%	4.1%	2.8%	5.58%	6.71%	-12.43%
FCF Growth %	22.63%	2.38%	19.34%	-53%	28.24%	-44.49%	-26.06%	119.97%	34.59%	-304.77%
FCF per Share	4.05	4.15	4.93	2.33	2.97	1.64	1.21	2.64	3.53	-7.22
FCF Conversion (FCF/Net Income)	2.45x	2.42x	2.61x	1.77x	2.48x	1.74x	2.60x	2.42x	2.20x	-0.00x
Interest Paid	164.3M	150.5M	149.6M	155.7M	168.4M	168.4M	178.4M	147.7M	146.8M	0
Taxes Paid	33.3M	96.4M	115.4M	104.2M	34.3M	131.4M	51.2M	109.3M	164.5M	0

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	25.17%	19.99%	16.62%	18.86%	14.45%	18.73%	12.72%	16.93%	17.71%	18.49%
Return on Invested Capital (ROIC)	12.08%	11.86%	12.05%	10.93%	-	8.87%	8.86%	25.98%	12.23%	12.74%
Gross Margin	96.16%	96.19%	96.29%	96.35%	95.21%	42.43%	40.32%	41.3%	41.56%	47.5%
Net Margin	6.8%	6.93%	6.83%	7.79%	7.97%	10.27%	6.23%	7.33%	8.48%	9.54%
Debt / Equity	2.83x	1.57x	1.34x	1.73x	1.77x	1.45x	1.61x	1.28x	0.95x	0.08x
Interest Coverage	3.77x	4.21x	4.63x	4.34x	-	4.01x	3.59x	12.02x	6.29x	6.17x
FCF Conversion	2.45x	2.42x	2.61x	1.77x	2.48x	1.74x	2.60x	2.42x	2.20x	-0.00x
Revenue Growth	16.91%	7.45%	9.28%	7.66%	-22.56%	12.58%	8.31%	10.41%	11.91%	10.46%

Encompass Health Corporation (EHC) 10-Year Financial Performance & Capital Metrics

Key Insights

✓Strengths

✗Weaknesses

Price & Volume

Growth Metrics

Revenue CAGR

Profit (Net Income) CAGR

EPS CAGR

ROCE

Peer Comparison

Compare EHC vs Peers

vs ENSG

vs BKD

Compare Top 5

Profit & Loss

Balance Sheet

Cash Flow

Key Ratios

Deep Dive Analysis

Valuation Overview

Total Return Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Encompass Health Corporation (EHC) 10-Year Financial Performance & Capital Metrics

Key Insights

✓Strengths

✗Weaknesses

Price & Volume

Growth Metrics

Revenue CAGR

Profit (Net Income) CAGR

EPS CAGR

ROCE

Peer Comparison

Compare EHC vs Peers

vs ENSG

vs BKD

Compare Top 5

Profit & Loss

Balance Sheet

Cash Flow

Key Ratios

Deep Dive Analysis

Valuation Overview

Total Return Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios